ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 109825 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 109825; 2) Community: the network communities that were significantly associated with the response to NSC 109825; 3) Molecule: the relationships between components within communities and NSC 109825; 4) MDR: the compounds that were significantly associated with the NSC 109825.

NSC Compound Enrichment Correlation
NSC 720134 Null 0.0352028253287042 0.13895944
NSC 731704 1-[4-Ethoxycarbonyl)homopiperazine-1-yl]diazen-1-ium-1,2-dio late. 0.0352028253287042 -0.10170618
NSC 743433 8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one 0.0352028253287042 -0.19993071
NSC 743532 Null 0.0352028253287042 -0.18595347
NSC 748147 5-methyl-2-{[(2)-3-phenylprop-2-enoyl]amino}benzamide 0.0352028253287042 0.086615694
NSC 750050 Null 0.0352028253287042 0.08072648
NSC 752761 Null 0.0352028253287042 0.24587839
NSC 753377 3-[2-(1-methyl-1H-indol-3-yl)-1,3-thiazol-4-yl]-1-methyl-1H-pyrrolo[2,3-b]pyridine 0.0352028253287042 0.23648034
NSC 762901 trans-4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-cyclohexyloxy}-pyridine-2-carboxylic acid methylamide 0.0352028253287042 -0.079110948
NSC 9594 Safranin bluish 0.0352028253287042 -0.072394478
Total:59  Current:38    [First] [Prev] [Next] [Last]